Analysis of Pleurotin binding to human thioredoxin reductase using docking and molecular dynamics simulation

Daniel B Quintanilha1, Hélio F Dos Santos1

  • 1NEQC: Núcleo de Estudos em Química Computacional, Departamento de Química, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.

Insights

Pleurotin, a natural compound from Hohenbuehelia grisea fungus, shows potential as a thioredoxin reductase (TrxR) inhibitor. This discovery offers a new avenue for cancer chemotherapy by targeting cellular redox homeostasis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Thioredoxin reductase (TrxR) is crucial for cellular redox homeostasis and a potential target for cancer chemotherapy.
  • Interfering with TrxR function can induce apoptosis, a key tumor suppression mechanism.
  • Despite extensive research, no TrxR inhibitors have been approved for human therapy.

Purpose of the Study:

  • To identify novel natural organic compounds as potential TrxR inhibitors through virtual screening.
  • To investigate the binding mechanism and allosteric effects of identified inhibitors.
  • To provide quantitative insights into ligand-receptor interactions using molecular dynamics.

Main Methods:

  • Virtual screening of 72 natural organic compounds with known IC-50 values for TrxR inhibition.
  • Molecular docking to predict binding modes and interactions within the TrxR active site.
  • Long molecular dynamics simulations to analyze binding energies and conformational changes.

Main Results:

  • Pleurotin, a naphthoquinone from Hohenbuehelia grisea, was identified as a promising TrxR inhibitor.
  • Pleurotin binds to the TrxR active site, hindering essential conformational changes required for enzyme function.
  • Simultaneous docking revealed allosteric correlation between the two binding sites, where one ligand can impede the binding of another.

Conclusions:

  • Pleurotin represents a potential lead compound for developing new cancer therapeutics targeting TrxR.
  • Understanding the allosteric interactions of TrxR inhibitors is crucial for drug design.
  • Molecular dynamics simulations offer a comprehensive approach to characterizing ligand-enzyme interactions.